Stockscreener 앱 받기
0.55
0.00%
0.00
시간 외 거래:
.55
전일 마감가:
$0.55
열려 있는:
$0.5349
하루 거래량:
365.02K
Relative Volume:
0.07
시가총액:
$6.14M
수익:
-
순이익/손실:
$-47.68M
주가수익비율:
-0.022
EPS:
-24.9619
순현금흐름:
$-23.09M
1주 성능:
-14.04%
1개월 성능:
+3.48%
6개월 성능:
-67.84%
1년 성능:
-92.58%
1일 변동 폭
$0.5254
$0.58
1주일 범위
$0.5165
$0.7385
52주 변동 폭
$0.3608
$14.71
BiomX Inc Stock (PHGE) Company Profile
명칭
BiomX Inc
전화
972 7 23942377
주소
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.55 | 6.19M | 0 | -47.68M | -23.09M | -24.96 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-15 | 개시 | Ladenburg Thalmann | Buy |
BiomX Inc 주식(PHGE)의 최신 뉴스
Number of shareholders of BiomX Inc. – AMEX:PHGE - TradingView
PHGE Q4 2025 Earnings: Significant EPS Miss Amid Clinical-Stage LossesOne-Time Gain Impact - newsline.com
PHGE - Finviz
BiomX Wins NYSE Compliance Plan Extension to 2027 - TipRanks
BiomX Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
BiomX (PHGE) wins NYSE American plan period after equity deficit warning - Stock Titan
BiomX gets more time to fix NYSE listing compliance issues - Stock Titan
BiomX (PHGE) details Zorronet and Dr. Frucht Systems acquisition financials - Stock Titan
PHGE Should I Buy - Intellectia AI
BiomX Inc. Publishes Review on the Future of AI in Security Industry by Zorronet CEO Idan Wasserman - Quiver Quantitative
Why stadium security AI must learn crowd behavior, not just spot threats - Stock Titan
BiomX Company Profile & Introduction - Moomoo
Large new equity pool and board election at BiomX (PHGE) 2026 meeting - Stock Titan
· Analyst Forecast - MLQ.ai
PHGE Q4 2025 Earnings: Wider-than-Expected Loss Sends Shares LowerEarnings Weakness Phase - newsline.com
BiomX Inc. Enters Line of Credit Agreement and Issues 12% Convertible Promissory Note – SEC 8-K Filing June 2026 - Minichart
BiomX subsidiary launches mobile command app for operators - Investing.com
BiomX Issues Restricted Shares Under Mandragola Credit Facility - TipRanks
BiomX (NYSE: PHGE) converts debt to shares and grants 2M-share warrant - Stock Titan
BiomX Inc. Appoints Former Elbit Systems Chief Scientist Gabby Sarusi to Board of Directors - geneonline.com
BiomX announces CEO and board changes, appoints Michael Oster as chief executive - Investing.com
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit - The Manila Times
BiomX Inc. Appoints Prof. Gabby Sarusi as Strategic Advisor to Enhance Defense and Security Capabilities - Moomoo
Ex-Elbit defense scientist joins BiomX push into threat-detection tech - Stock Titan
BiomX expands Zorronet's AI C5ISR suite for secure on-premise defense and critical infrastructure use. - Pluang
Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud Dependence - The Manila Times
AI security system moves on-site: no public cloud for hardened facilities - Stock Titan
PHGE Q4 2025 Earnings: EPS Miss of -$8.17 Amid Continued Clinical DevelopmentMid-Term Outlook - newsline.com
BiomX Appoints Roy Rousso as Chief Business Officer - The Globe and Mail
Deerfield funds report 8.09% BiomX (PHGE) ownership after warrant and preferred conversions - Stock Titan
BiomX Inc. Appoints Roy Rousso as Chief Business Officer Effective July 1, 2026 – Details of Consulting Agreement - Minichart
BiomX appoints Roy Rousso as Chief Business Officer - TradingView
BiomX (NYSE: PHGE) hires Roy Rousso as new Chief Business Officer - Stock Titan
BiomX Inc. (PHGE) Q4 2025 Earnings: EPS Misses by Wide Margin, No Revenue, Stock DeclinesEarnings Quality Analysis - The Legal Advocate
BiomX (PHGE) Appoints New Chief Business Officer to Strengthen L - GuruFocus
BiomX appoints Roy Timor-Rousso as chief business officer By Investing.com - Investing.com India
BiomX Inc. (PHGE) Slides 7%: Crucial Support Test Nears as Selling Pressure IntensifiesGrowth Factor - The Legal Advocate
BiomX (PHGE) Appoints New Chief Business Officer to Strengthen Leadership - GuruFocus
BiomX appoints Roy Timor-Rousso as chief business officer - Investing.com
BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security Operations - The Manila Times
BiomX Inc. Announces the Appointment of Roy Timor-Rousso as Chief Business Officer - marketscreener.com
BiomX Inc. (PHGE) Q4 2025 Earnings: Deep EPS Miss Overshadowed by 98% Stock SurgeEBITDA Estimate Trend - newsline.com
PHGE Stock Jumps As BiomX Launches AI Command App - StocksToTrade
PHGE Stock Pops As BiomX Unveils AI Command App - timothysykes.com
BiomX Inc. (PHGE) Surges 10.5%: Can the Rally Hold Above $0.78 Support?Point of Control - Newser
PHGE Q4 2025 Earnings: EPS Misses Estimates Significantly, Stock Rises 10.5%Profit Margin Analysis - newsline.com
PHGE Q4 2025 Earnings: Severe EPS Miss as BiomX Continues Clinical DevelopmentSmart Trader Community - Newser
BiomX Inc (PHGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.60%
0.94%
자본화:
|
볼륨(24시간):